MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis
NASDAQ:MDLZ - Nasdaq - US6092071058 - Common Stock - Currency: USD
MDLZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. While MDLZ has a great profitability rating, there are quite some concerns on its financial health. MDLZ has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
In the past year MDLZ had a positive cash flow from operations.
In the past 5 years MDLZ has always been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
The Return On Assets of MDLZ (5.22%) is better than 67.78% of its industry peers.
Looking at the Return On Equity, with a value of 13.97%, MDLZ is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
The Return On Invested Capital of MDLZ (6.95%) is better than 71.11% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MDLZ is in line with the industry average of 8.67%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 13.97% | ||
| ROIC | 6.95% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
With an excellent Profit Margin value of 9.88%, MDLZ belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
MDLZ's Profit Margin has declined in the last couple of years.
The Operating Margin of MDLZ (12.62%) is better than 81.11% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a Gross Margin of 32.74%. This is in the better half of the industry: MDLZ outperforms 74.44% of its industry peers.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.62% | ||
| PM (TTM) | 9.88% | ||
| GM | 32.74% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
MDLZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
MDLZ has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MDLZ has an improved debt to assets ratio.
2.2 Solvency
MDLZ has an Altman-Z score of 2.52. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of MDLZ (2.52) is comparable to the rest of the industry.
The Debt to FCF ratio of MDLZ is 5.90, which is a neutral value as it means it would take MDLZ, 5.90 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.90, MDLZ is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: MDLZ underperforms 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 5.9 | ||
| Altman-Z | 2.52 |
ROIC/WACC0.87
WACC7.97%
2.3 Liquidity
MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ has a worse Current ratio (0.61) than 86.67% of its industry peers.
MDLZ has a Quick Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ's Quick ratio of 0.40 is on the low side compared to the rest of the industry. MDLZ is outperformed by 78.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.4 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased by -3.86% in the last year.
The Earnings Per Share has been growing slightly by 6.91% on average over the past years.
MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 0.90%.
Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.09% on average per year.
EPS 1Y (TTM)-3.86%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.11%
Revenue 1Y (TTM)0.9%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%0.25%
3.2 Future
The Earnings Per Share is expected to grow by 4.43% on average over the next years.
The Revenue is expected to grow by 3.62% on average over the next years.
EPS Next Y-10.75%
EPS Next 2Y-0.93%
EPS Next 3Y2.37%
EPS Next 5Y4.43%
Revenue Next Year4.78%
Revenue Next 2Y4.5%
Revenue Next 3Y4.26%
Revenue Next 5Y3.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
MDLZ is valuated rather expensively with a Price/Earnings ratio of 20.49.
MDLZ's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.91, MDLZ is valued a bit cheaper.
A Price/Forward Earnings ratio of 19.61 indicates a rather expensive valuation of MDLZ.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than the industry average as 64.44% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, MDLZ is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.49 | ||
| Fwd PE | 19.61 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.95 | ||
| EV/EBITDA | 17.07 |
4.3 Compensation for Growth
The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.96
EPS Next 2Y-0.93%
EPS Next 3Y2.37%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 2.89%. Purely for dividend investing, there may be better candidates out there.
MDLZ's Dividend Yield is a higher than the industry average which is at 4.58.
MDLZ's Dividend Yield is a higher than the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.89% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 10.52%!
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
66.48% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP66.48%
EPS Next 2Y-0.93%
EPS Next 3Y2.37%
NASDAQ:MDLZ (5/23/2025, 2:38:08 PM)
66.39
+0.9 (+1.37%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners85.54%
Inst Owner Change2.56%
Ins Owners0.14%
Ins Owner Change3.27%
Market Cap85.96B
Analysts75.56
Price Target73.07 (10.06%)
Short Float %1.64%
Short Ratio2.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.89% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP66.48%
Div Incr Years10
Div Non Decr Years10
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.56%
Min EPS beat(2)-3.07%
Max EPS beat(2)10.18%
EPS beat(4)3
Avg EPS beat(4)7.09%
Min EPS beat(4)-3.07%
Max EPS beat(4)14.26%
EPS beat(8)7
Avg EPS beat(8)6.28%
EPS beat(12)11
Avg EPS beat(12)5.79%
EPS beat(16)12
Avg EPS beat(16)4.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-2.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)-0.99%
Revenue beat(8)2
Avg Revenue beat(8)-1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.53%
Revenue beat(16)9
Avg Revenue beat(16)0.62%
PT rev (1m)5.22%
PT rev (3m)-1.82%
EPS NQ rev (1m)4.26%
EPS NQ rev (3m)3.14%
EPS NY rev (1m)3.58%
EPS NY rev (3m)4.06%
Revenue NQ rev (1m)3.07%
Revenue NQ rev (3m)3.39%
Revenue NY rev (1m)1.87%
Revenue NY rev (3m)1.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.49 | ||
| Fwd PE | 19.61 | ||
| P/S | 2.36 | ||
| P/FCF | 25.95 | ||
| P/OCF | 18.38 | ||
| P/B | 3.33 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.07 |
EPS(TTM)3.24
EY4.88%
EPS(NY)3.39
Fwd EY5.1%
FCF(TTM)2.56
FCFY3.85%
OCF(TTM)3.61
OCFY5.44%
SpS28.16
BVpS19.91
TBVpS-12.96
PEG (NY)N/A
PEG (5Y)2.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 13.97% | ||
| ROCE | 9.6% | ||
| ROIC | 6.95% | ||
| ROICexc | 7.17% | ||
| ROICexgc | 60.64% | ||
| OM | 12.62% | ||
| PM (TTM) | 9.88% | ||
| GM | 32.74% | ||
| FCFM | 9.09% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexcg growth 3Y30.99%
ROICexcg growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 5.9 | ||
| Debt/EBITDA | 3 | ||
| Cap/Depr | 104.44% | ||
| Cap/Sales | 3.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.15% | ||
| Profit Quality | 92% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.4 | ||
| Altman-Z | 2.52 |
F-Score5
WACC7.97%
ROIC/WACC0.87
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.11%
EPS Next Y-10.75%
EPS Next 2Y-0.93%
EPS Next 3Y2.37%
EPS Next 5Y4.43%
Revenue 1Y (TTM)0.9%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%0.25%
Revenue Next Year4.78%
Revenue Next 2Y4.5%
Revenue Next 3Y4.26%
Revenue Next 5Y3.62%
EBIT growth 1Y-33.55%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year7.92%
EBIT Next 3Y7.96%
EBIT Next 5Y8.23%
FCF growth 1Y12.76%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y19.95%
OCF growth 3Y5.84%
OCF growth 5Y4.37%